Key Insights

Highlights

Success Rate

70% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 42/100

Termination Rate

26.1%

6 terminated out of 23 trials

Success Rate

70.0%

-16.5% vs benchmark

Late-Stage Pipeline

43%

10 trials in Phase 3/4

Results Transparency

71%

10 of 14 completed with results

Key Signals

10 with results70% success

Data Visualizations

Phase Distribution

21Total
Not Applicable (6)
P 2 (5)
P 3 (6)
P 4 (4)

Trial Status

Completed14
Terminated6
Unknown2
Recruiting1

Trial Success Rate

70.0%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT06934785Not ApplicableRecruiting

LE + CC vs. LE for Ovulation Induction

NCT06725004Phase 3CompletedPrimary

Oxytocin Versus Human Chorionic Gonadotropin as Trigger in Ovulation Induction

NCT02496754Not ApplicableCompleted

Follicular Long GnRH Agonist Versus Antagonist Protocol in PCOS Women Undergoing in Vitro Fertilization

NCT00697255Phase 2TerminatedPrimary

A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693)

NCT04306692Phase 4TerminatedPrimary

Myo-inositol Versus Clomiphene Citrate in PCOS

NCT04834791Phase 4Completed

Letrozole Versus Gonadotropins in Clomiphene Citrate Resistance

NCT04610957Not ApplicableCompletedPrimary

Effect of Adding Isoflavonoids to Clomiphene Citrate for Ovulation Induction in Women With Polycystic Ovary Syndrome

NCT03825445Not ApplicableCompletedPrimary

GnRH Agonist Versus hCG Trigger in Ovulation Induction With Intrauterine Insemination.

NCT00823472Phase 4Terminated

Trial Comparing Start Stimulation of Recombinant Follicle Stimulating Hormone (rFSH) on Cycle Day 2 Versus Cycle Day 5 in In Vitro Fertilization (IVF)

NCT01183143Phase 3Completed

Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro Fertilization

NCT01110707Phase 2Completed

A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Combined Treatment of Lutropin Alpha and Recombinant Human Luteinizing Hormone in the Middle of the Controlled Ovarian Stimulation Follicular Phase in Women With Reduced Ovarian Reserve

NCT03396380Phase 3UnknownPrimary

Effect of Vitamin D Supplement in Induction of Ovulation in Overweight Women With Polycystic Ovary Syndrome

NCT01008319Phase 3Completed

Traditional Clomiphene Citrate Administration vs. Stair-step Approach

NCT03307720Not ApplicableUnknownPrimary

Agonist Versus Classical HCG Trigger (Poor Responders, Normoresponders and High Responders)

NCT01645241Not ApplicableCompleted

Evolutive Potential of Embryos Obtained From Oocytes After Luteal Phase Ovarian Stimulation

NCT01081639Phase 3Completed

To Evaluate the Convenience, Safety and Efficacy of Follitropin Alfa Liquid Pen Compared With Follitropin Beta Liquid Pen

NCT01111084CompletedPrimary

A Prospective, Multi-centric Observational Study to Determine the Mono-bifollicular Development in Infertile Women Subjected to Ovulation Induction With Follitropin α

NCT01079949Phase 2Terminated

A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age

NCT01081626Phase 4CompletedPrimary

Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction

NCT01075815Phase 2Terminated

A Clinical Trial to Determine the Effect of Lutropin Alfa on Embryo Quality and Implantation Rate in Advanced Reproductive Age

Scroll to load more

Research Network

Activity Timeline